Smoking more harmful than HIV for people taking effective treatment, US study suggests
Dolutegravir regimen highly effective in clinical trial for women
Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV
Four days on, three days off HIV treatment controls viral load in French pilot study
Darunavir/ritonavir & lamivudine matches triple-drug therapy
New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy
Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels
The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears
Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk
